[1] |
张忠涛,张鹏. 腹腔镜减重与代谢外科治疗现状与发展[J/CD]. 中华普外科手术学杂志(电子版),2020,14(2):109-112.
|
[2] |
朱晒红,李鹏洲,高祥,等. 腹腔镜减重代谢袖状胃手术要点与适应证[J/CD]. 中华普外科手术学杂志(电子版),2020,14(2):113-116.
|
[3] |
Skogar ML, Sundbom M. Weight loss and effect on co-morbidities in the long-term after duodenal switch and gastric bypass: a population-based cohort study[J]. Surg Obes Relat Dis,2020,16(1):17-23.
|
[4] |
Yashkov Y, Bordan N, Torres A, et al. SADI-S 250 vs Roux-en-Y Duodenal Switch (RY-DS): Results of 5-Year Observational Study[J]. Obes Surg,2021,31(2):570-579.
|
[5] |
Baltasar A, Bou R, Perez N, et al. [Twenty-five years of duodenal switch. How to switch to the duodenal switch][J]. Nutr Hosp,2019,36(6):1278-1287.
|
[6] |
中国医师协会高血压专业委员会. 中国医师协会关于我国高血压诊断标准及降压目标科学声明[J]. 中国实用内科杂志,2018,38(4):348-350.
|
[7] |
中华医学会内分泌学分会. 中国高尿酸血症与痛风诊疗指南(2019)[J]. 中华内分泌代谢杂志,2020,36(1):1-13.
|
[8] |
American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020[J]. Diabetes Care,2020,43(Suppl 1):S14-S31.
|
[9] |
Brethauer SA, Kim J, el Chaar M, et al. Standardized outcomes reporting in metabolic and bariatric surgery[J]. Obes Surg,2015,11(3): 489-506.
|
[10] |
Anthone GJ, Lord RVN, DeMeester TR, et al. The duodenal switch operation for the treatment of morbid obesity[J]. Ann Surg,2003,238(4): 618-627; discussion 627-628.
|
[11] |
Scopinaro N, Gianetta E, Civalleri D, et al. Bilio-pancreatic bypass for obesity: II. Initial experience in man[J]. Br J Surg,1979,66(9):618-620.
|
[12] |
Lagace M, Marceau P, Marceau S, et al. Biliopancreatic Diversion with a New Type of Gastrectomy: Some Previous Conclusions Revisited[J]. Obes Surg,1995,5(4):411-418.
|
[13] |
Hess D S, Hess D W. Biliopancreatic diversion with a duodenal switch[J]. Obes Surg,1998,8(3):267-282.
|
[14] |
Kapeluto JE, Tchernof A, Masckauchan D, et al. Ten-year remission rates in insulin-treated type 2 diabetes after biliopancreatic diversion with duodenal switch[J]. Surg Obes Relat Dis,2020,16(11):1701-1712.
|
[15] |
Angrisani L, Santonicola A, Iovino P, et al. IFSO Worldwide Survey 2016: Primary, Endoluminal, and Revisional Procedures[J]. Obes Surg,2018,28(12):3783-3794.
|
[16] |
Skogar ML, Sundbom M. Early complications, long-term adverse events, and quality of life after duodenal switch and gastric bypass in a matched national cohort[J]. Surg Obes Relat Dis,2020,16(5):614-619.
|
[17] |
Finno P, Osorio J, Garcia-Ruiz-de-Gordejuela A, et al. Single Versus Double-Anastomosis Duodenal Switch: Single-Site Comparative Cohort Study in 440 Consecutive Patients[J]. Obes Surg,2020,30(9):3309-3316.
|
[18] |
Oviedo RJ, Nayak T, Liu Y, et al. Laparoscopic Duodenal Switch Versus Roux-en-Y Gastric Bypass at a High-Volume Community Hospital: a Retrospective Cohort Study from a Rural Setting[J]. Obes Surg,2021,31(2):659-666.
|
[19] |
Pereira AM, Guimaraes M, Pereira SS, et al. Single and dual anastomosis duodenal switch for obesity treatment: a single-center experience[J]. Surg Obes Relat Dis,2021,17(1):12-19.
|
[20] |
Sneineh MA, Harel L, Elnasasra A, et al. Increased Incidence of Symptomatic Cholelithiasis After Bariatric Roux-En-Y Gastric Bypass and Previous Bariatric Surgery: a Single Center Experience[J]. Obes Surg,2020,30(3):846-850.
|
[21] |
Altieri MS, Yang J, Nie L, et al. Incidence of cholecystectomy after bariatric surgery[J]. Surg Obes Relat Dis,2018,14(7):992-996.
|
[22] |
Dincer M, Dogan F. The effect of concomitant cholecystectomy and sleeve gastrectomy on morbidity in high-risk obese patients with symptomatic gallstones[J]. Wideochir Inne Tech Maloinwazyjne,2019,14(2):237-241.
|
[23] |
Clapp B, Lee I, Liggett E, et al. Are Concomitant Operations During Bariatric Surgery Safe? An Analysis of the MBSAQIP Database[J]. Obes Surg,2020,30(11):4474-4481.
|
[24] |
Yardimci S, Coskun M, Demircioglu S, et al. Is Concomitant Cholecystectomy Necessary for Asymptomatic Cholelithiasis During Laparoscopic Sleeve Gastrectomy?[J]. Obes Surg,2018,28(2):469-473.
|